The therapeutic possibilities of L-dopa and amantadine in Parkinsonian patients who have undergone bilateral thalamotomy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000547:Amantadine / Q000627:therapeutic use*; D002648:Child; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*; D013238:Stereotaxic Techniques; D013788:Thalamus / Q000601:surgery*; D014202:Tremor / Q000188:drug therapy; D014705:Verbal Behavior / Q000188:drug therapy
D004295:Dihydroxyphenylalanine; D000547:Amantadine